Myomo (MYO) Income from Non-Controlling Interests (2019)
Myomo (MYO) posted Income from Non-Controlling Interests of -$2.8 million for Q4 2019, up 0.95% on a QoQ basis from -$2.8 million in Q3 2019.
Myomo (MYO) Income from Non-Controlling Interests (2019) Analysis & Trends
Myomo's Income from Non-Controlling Interests history runs 1 years deep, the most recent figure standing at -$2.8 million for Q4 2019.
- Quarterly Income from Non-Controlling Interests changed N/A year-over-year to -$2.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was -$11.5 million (changed N/A YoY) and the FY2019 annual result came in at -$11.5 million, changed N/A from the prior year.
- Income from Non-Controlling Interests was -$2.8 million for Q4 2019 at Myomo, up from -$2.8 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at -$2.6 million in Q2 2019 and bottomed at -$3.4 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -2.76 Mn |
| Sep 30, 2019 | -2.79 Mn |
| Jun 30, 2019 | -2.57 Mn |
| Mar 31, 2019 | -3.40 Mn |